Illumina has significant market share in genomics. How would they reach beyond their current users to grow the market for genomics analysis? A podcast of course! Paul Bromann is a Scientific …
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit cclifescience.substack.com
view more